These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25764276)

  • 1. CRISPR-Cas Adaptive Immune Systems of the Sulfolobales: Unravelling Their Complexity and Diversity.
    Garrett RA; Shah SA; Erdmann S; Liu G; Mousaei M; León-Sobrino C; Peng W; Gudbergsdottir S; Deng L; Vestergaard G; Peng X; She Q
    Life (Basel); 2015 Mar; 5(1):783-817. PubMed ID: 25764276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.
    Yu Z; Jiang S; Wang Y; Tian X; Zhao P; Xu J; Feng M; She Q
    Sci China Life Sci; 2021 May; 64(5):678-696. PubMed ID: 33140167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heavily Armed Ancestors: CRISPR Immunity and Applications in Archaea with a Comparative Analysis of CRISPR Types in Sulfolobales.
    Zink IA; Wimmer E; Schleper C
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-based immune systems of the Sulfolobales: complexity and diversity.
    Garrett RA; Shah SA; Vestergaard G; Deng L; Gudbergsdottir S; Kenchappa CS; Erdmann S; She Q
    Biochem Soc Trans; 2011 Jan; 39(1):51-7. PubMed ID: 21265746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMV1 virus-induced CRISPR spacer acquisition from the conjugative plasmid pMGB1 in Sulfolobus solfataricus P2.
    Erdmann S; Shah SA; Garrett RA
    Biochem Soc Trans; 2013 Dec; 41(6):1449-58. PubMed ID: 24256236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR adaptive immune systems of Archaea.
    Vestergaard G; Garrett RA; Shah SA
    RNA Biol; 2014; 11(2):156-67. PubMed ID: 24531374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major and minor crRNA annealing sites facilitate low stringency DNA protospacer binding prior to Type I-A CRISPR-Cas interference in Sulfolobus.
    Mousaei M; Deng L; She Q; Garrett RA
    RNA Biol; 2016 Nov; 13(11):1166-1173. PubMed ID: 27618562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.
    Maikova A; Boudry P; Shiriaeva A; Vasileva A; Boutserin A; Medvedeva S; Semenova E; Severinov K; Soutourina O
    mBio; 2021 Aug; 12(4):e0213621. PubMed ID: 34425703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information.
    Fineran PC; Charpentier E
    Virology; 2012 Dec; 434(2):202-9. PubMed ID: 23123013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas and Cmr modules, mobility and evolution of adaptive immune systems.
    Shah SA; Garrett RA
    Res Microbiol; 2011 Jan; 162(1):27-38. PubMed ID: 20863886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
    Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
    RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids.
    Pinilla-Redondo R; Mayo-Muñoz D; Russel J; Garrett RA; Randau L; Sørensen SJ; Shah SA
    Nucleic Acids Res; 2020 Feb; 48(4):2000-2012. PubMed ID: 31879772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
    Plagens A; Richter H; Charpentier E; Randau L
    FEMS Microbiol Rev; 2015 May; 39(3):442-63. PubMed ID: 25934119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-mediated defense mechanisms in the hyperthermophilic archaeal genus Sulfolobus.
    Manica A; Schleper C
    RNA Biol; 2013 May; 10(5):671-8. PubMed ID: 23535277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.